LOS
ANGELES, Oct. 28, 2024 /PRNewswire/ -- The DJS
Law Group reminds investors of a class action lawsuit against Sage
Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE) for
violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated
thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of SAGE during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointments. Appointment as lead plaintiff is not
required to partake in any recovery.
CASE DETAILS: The investigation focuses on whether the
Company issued false and/or misleading statements and/or failed to
disclose information pertinent to investors.
If you are a shareholder who suffered a loss, contact us to
participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to
enhance investor return through balanced counseling and aggressive
advocacy. We specialize in securities class actions, corporate
governance litigation, and domestic/international M&A
appraisals. Our clients are some of the largest and most
sophisticated hedge funds and alternative asset managers in the
world. The litigation claims of our clients are extraordinarily
valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
CONTACT:
David J.
Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sage-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights---sage-302288232.html
SOURCE DJS Law Group LLP
